Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWAND.L Regulatory News (WAND)

  • There is currently no data for WAND

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

5 Dec 2017 07:00

RNS Number : 3587Y
WANdisco Plc
05 December 2017
 

5 December 2017

 

WANdisco plc

("WANdisco" or the "Company")

LEI: 213800Y1A75RSC698O04

 

Director/PDMR Shareholding

The Company was notified today that Karl Monaghan, non-executive director, purchased 8,900 ordinary shares of 10 pence each in the Company ("Ordinary Shares") for his SIPP at a price of 550p per share on 4 December 2016. As a result, the combined beneficial holding of Karl Monaghan, his wife and his son in the Company is 53,542 Ordinary Shares representing approximately 0.13 per cent. in aggregate of the Company's issued share capital of 40,903,941 ordinary shares.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Karl Monaghan

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

WANdisco plc

b)

LEI

213800Y1A75RSC698O04

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each

 

ISIN: JE00B6Y3DV84

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

550p

 8,900

 

d)

Aggregated information

-

Aggregated volume

-

Price

-

Aggregated total

 

 

8,900

550p

£48,950

e)

Date of the transaction

4 December 2017

f)

Place of the transaction

London Stock Exchange (XLON)

 

For further information, please contact:

 

WANdisco plc

Via Vigo Communications

David Richards, Chief Executive Officer and Interim Chairman

Erik Miller, Chief Financial Officer

Vigo Communications

+44 (0)207 830 9700

Jeremy Garcia / Fiona Henson / Antonia Pollock

www.vigocomms.com

Stifel (Nomad, Joint Broker)

+44 (0)207 710 7600

Fred Walsh / Neil Shah / Ben Maddison / Rajpal Padam

Peel Hunt (Joint Broker)

+44 (0)207 418 8900

Edward Knight / Nick Prowting

 

About WANdisco:

WANdisco is a world leader in Active Data Replication™. Its patented WANdisco Fusion technology enables the replication of continuously changing data to the cloud and on-premises data centers with guaranteed consistency, no downtime and no business disruption. It also allows distributed development teams to collaborate as if they are all working in one location. WANdisco currently has two OEM relationships with IBM and Dell/EMC's Virtustream as well as partnerships with Amazon Web Services, Cisco, Google Cloud, Hewlett Packard Enterprise, Microsoft Azure, and Oracle to resell its patented technology. WANdisco also works directly with Fortune 1000 companies around the world to ensure their data can give them the real insight they need.

For additional information, please visit www.wandisco.com.

This Announcement should be read in its entirety. In particular, you should read and understand the information provided in the "Important Notices" section of this Announcement.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUGGGCPUPMPUC
Date   Source Headline
4th Oct 20237:00 amRNSWANdisco plc rebrands as Cirata plc
22nd Sep 20236:24 pmRNSHolding(s) in Company
11th Sep 20237:00 amRNSInterim results
7th Sep 20233:30 pmRNSNotice of Results
30th Aug 20236:04 pmRNSResult of Annual General Meeting
18th Aug 20236:05 pmRNSBlock Admission Notification
16th Aug 20238:07 amRNSGM Signs Multi-Project Contract with WANdisco
31st Jul 20237:00 amRNSHolding(s) in Company
28th Jul 20233:25 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSBoard Changes
25th Jul 20237:30 amRNSRestoration - WANdisco plc
25th Jul 20237:00 amRNSConfirmation of Exchange Rate
24th Jul 202310:45 amRNSResult of GM
17th Jul 20235:00 pmRNSPosting of Annual Report and Accounts
12th Jul 20231:45 pmRNSPublication of Annual Report and Accounts
11th Jul 20237:00 amRNSContract Win
10th Jul 20237:00 amRNSContract Renewal
7th Jul 20237:00 amRNSConfirmation of Fundraise
5th Jul 20236:29 pmRNSPublication of Notice of General Meeting
5th Jul 202311:30 amRNSUpdate to Fundraise Timetable
4th Jul 20237:00 amRNSResult of Fundraising
3rd Jul 202312:00 pmRNSLaunch of Fundraise
29th Jun 20237:00 amRNSPreliminary Unaudited Results FY22
28th Jun 202311:51 amRNSUpdate on Timing of Results and Equity Issue
26th Jun 20233:30 pmRNSTurnaround Plan Momentum
26th Jun 20237:00 amRNSWANdisco Signs New Agreement with Accenture
15th Jun 20239:46 amRNSFCA investigation timeline update
9th Jun 20237:00 amRNSSuccessful Shareholder General Meeting Next Steps
6th Jun 20233:49 pmRNSResult of General Meeting
19th May 20236:22 pmRNSPublication of Circular and Notice of GM
19th May 20236:04 pmRNSBoard Change
15th May 20237:00 amRNSExploring Funding Options
9th May 20235:30 pmRNSWANdisco
9th May 20237:00 amRNSAppointment of Interim Chief Executive
4th May 20237:00 amRNSOrganisation Update
28th Apr 20237:00 amRNSIndependent Investigation Update
20th Apr 20237:00 amRNSFCA Investigation
5th Apr 20237:00 amRNSExecutive Chair Appointment Confirmation
4th Apr 20237:00 amRNSContract Renewals
3rd Apr 20237:00 amRNSBoard Change and Investigation Update
22nd Mar 20237:00 amRNSAppointment of Interim Chair
10th Mar 20239:31 amRNSIndependent Investigation Appointment
9th Mar 20237:30 amRNSSuspension - WANdisco plc
9th Mar 20237:00 amRNSTrading Revision
7th Mar 20237:00 amRNSAppointment of Joint Broker
6th Mar 20237:00 amRNSResponse to press speculation
1st Mar 20238:16 amRNSTotal Voting Rights
1st Feb 20234:05 pmRNSTotal Voting Rights
24th Jan 20237:00 amRNS$9m industrial and consumer goods contract win
11th Jan 20237:00 amRNSFY22 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.